Notably, PD-L1, a known tumorigenic factor that is carried by the plasma exosomes from HNSCC patients, is linked to disease progression, as the blocking of PD-L1 signaling attenuates immune suppression [50]. This evidence concerns the gene CD274 and head and neck squamous cell carcinoma.